Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study

BACKGROUND: [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomography ([(18)F]FDG-PET/CT) has been implemented sporadically in hospital settings as the standard of care examination for recurrent breast cancer. We aimed to explore the clinical impact of implementing [(18)F]FDG-PET/C...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogsen, Marianne, Jensen, Jeanette Dupont, Gerke, Oke, Jylling, Anne Marie Bak, Asmussen, Jon Thor, Christensen, Ivar Yannick, Braad, Poul-Erik, Thye-Rønn, Peter, Søe, Katrine Lydolph, Ewertz, Marianne, Hildebrandt, Malene Grubbe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458550/
https://www.ncbi.nlm.nih.gov/pubmed/34553294
http://dx.doi.org/10.1186/s13550-021-00833-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458550/
https://www.ncbi.nlm.nih.gov/pubmed/34553294
http://dx.doi.org/10.1186/s13550-021-00833-3

Ejemplares similares